In the news

Servier’s Wehealth, Pathmaker team up for neuromodulation device for spasticity treatment (BioWorld MedTech, January 2019)

Pathmaker inks $5M deal to develop neuromodulation device for muscle spasticity (BioWorld MedTech, February 2018)

MyoAmplifier Gets Seed Funding to Develop System for Pediatric Paralysis (Cerebral Palsy News Today, January 2018)

BPIFrance Awards PathMaker Grant to Develop MyoRegulator, Device to Treat Spasticity (Multiple Sclerosis News Today, February 2017)

The Brain Forum Video

Clinical Trial Begins for Device to Treat Spasticity in Cerebral Palsy, Other Disorders (Cerebral Palsy News Today, April 2016)

PathMaker Launches Clinical Trial of MyoRegulator to Treat Spasticity, Common in MS (Multiple Sclerosis News Today, April 2016)

Neuromodulator and artificial kidney to be reviewed under FDA’s Expedited Access Pathway (FierceMedicalDevices, November 2015)

FDA speeds up approval process for PathMaker’s non-invasive medical device (Boston Business Journal, October 2015)

Hello Tomorrow Challenge Video

PathMaker Neurosystems Inc. eyes European market with France expansion (Boston Business Journal, June 2015)

Faculty Focus:  New Frontiers in Rehabilitation (CUNY/CSI)

Treatment being studied at College of Staten Island stimulates the brain, spinal cord and muscles in those with cerebral palsy, stroke (SI Live)

A New Path to Mobility (CUNY video)

New Treatment May Help Paralyzed Patients Move Again (NY1 News)

Zaghloul Ahmed Awarded 2011 NYC Bioaccelerate Prize For Neural Stimulation System